Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Voliphage-M 0.2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Franco-Indian Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Voliphage-M 0.2 Tablet SR

Diabetease-M 0.2mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetease-M 0.2mg ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood glucose response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Potential side effects include nausea, altered taste perception, appetite suppression, flatulence, abdominal discomfort, diarrhea, and dermatological reactions. These are usually transient and self-limiting; however, persistent or concerning effects warrant medical attention. Your physician can offer management strategies for bothersome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Use during pregnancy or lactation requires physician consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Voliphage-M 0.2 Tablet SR

No text provided to rephrase.

Uses of Voliphage-M 0.2 Tablet SR

Managing Type 2 diabetes

Major Benefits of Voliphage-M 0.2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voliphage-M 0.2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Voliphage-M 0.2 Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Voliphage-M 0.2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Voliphage-M 0.2 SR tablets with food.

How Voliphage-M 0.2 Tablet SR works:

Sustained-release Voliphage-M 0.2mg tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voliphage-M 0.2 Tablet SR with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Voliphage-M 0.2mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Voliphage-M 0.2mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Extended-release Voliphage-M 0.2mg tablets typically do not impair driving ability. Nevertheless, concurrent use with other diabetes medications, including sulfonylureas, insulin, and repaglinide, necessitates caution due to the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Voliphage-M 0.2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Voliphage-M 0.2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Voliphage-M 0.2 Tablet SR in individuals with hepatic impairment. Seek medical advice.

What if you forget to take Voliphage-M 0.2 Tablet SR :

Should you forget to take a Voliphage-M 0.2 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voliphage-M 0.2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Voliphage-M 0.2 Tablet SR
89
MRP 104
14% off